Optimizing Treatment for HR+/HER2- Breast Cancer: A Multidisciplinary Approach

Expert oncologists review data presented at recent conferences and discuss current multidisciplinary strategies for the treatment of patients with HR+/HER2- breast cancer.

EP. 1: Importance of Multidisciplinary Care for Patients With HR+/HER- Breast Cancer

August 22nd 2023

A panel of experts explains the importance of a multidisciplinary team in treating HR+/HER2- breast cancer to ensure comprehensive and coordinated care throughout the patient's journey.

EP. 2: Barriers to Optimal Care in Patients With HR+/HER- Breast Cancer

August 22nd 2023

Key opinion leaders detail various barriers to optimal care for patients with HR+/HER2- breast cancer, including transportation issues, financial difficulties, lack of family support, and challenges in coordinating care among different medical specialists.

EP. 3: Clinical Scenario: A 60-Year-Old Woman With Newly Diagnosed Breast Cancer

August 30th 2023

Naomi Dempsey, MD, presents the clinical scenario of a 60-year-old woman with newly diagnosed HR+/HER- breast cancer to the panel for discussion.

EP. 4: Considerations for Chemotherapy Dosing in Patients With HR+/HER- Breast Cancer

August 30th 2023

The panel discusses the importance of careful chemotherapy dosing and management of side effects for patients with HR+/HER- breast cancer, including the use of cooling and compression gloves to prevent peripheral neuropathy.

EP. 5: Helping Patients With HR+/HER2- Breast Cancer Access Abemaciclib

September 6th 2023

Experts explain the challenges patients with HR+/HER- breast cancer face in accessing abemaciclib for treatment and the options available such as patient assistance programs for high co-pays.

EP. 6: Updates in Adjuvant Therapy for HR+/HER- Breast Cancer From ASCO 2023: The NATALEE Trial

September 6th 2023

Dr Naomi Dempsey shares the study design, primary outcome data, and the 3-year invasive disease-free survival follow-up data from the NATALEE trial in HR+/HER2- breast cancer presented at ASCO 2023.

EP. 7: Monitoring and Treating Lymphedema in Patients With HR+/HER- Breast Cancer

September 13th 2023

Nadia Nocera Zachariah, MD, explains why early detection and monitoring of lymphedema is crucial in patients with HR+/HER- breast cancer, with technologies like prophylactic compression sleeves and nighttime compression systems showing promise in reducing negative impact on quality of life.